| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |